BFRIW
Price:
$0.08
Market Cap:
$5.54M
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
Stock Exchange
NASDAQ
Ticker
BFRIW
According to Biofrontera Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.60M. This represents a change of -68.75% compared to the average of 8.34M of the last 4 quarters.
The mean historical Enterprise Value of Biofrontera Inc. over the last ten years is 48.69M. The current 2.60M Enterprise Value has changed 434.90% with respect to the historical average. Over the past ten years (40 quarters), BFRIW's Enterprise Value was at its highest in in the March 2020 quarter at 60.24M. The Enterprise Value was at its lowest in in the September 2022 quarter at -3655889.00.
Average
48.69M
Median
43.08M
Minimum
3.52M
Maximum
104.08M
Discovering the peaks and valleys of Biofrontera Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.63%
Maximum Annual Enterprise Value = 104.08M
Minimum Annual Increase = -96.62%
Minimum Annual Enterprise Value = 3.52M
Year | Enterprise Value | Change |
---|---|---|
2023 | 8.34M | 136.70% |
2022 | 3.52M | -96.62% |
2021 | 104.08M | 141.63% |
2020 | 43.08M | -48.98% |
The current Enterprise Value of Biofrontera Inc. (BFRIW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
38.65M
5-year avg
48.69M
10-year avg
48.69M
Biofrontera Inc.’s Enterprise Value is less than Biofrontera Inc. (2.60M), greater than Pasithea Therapeutics Corp. (-4187996.00), less than Inspira Technologies Oxy B.H.N. Ltd. (19.23M), greater than Bluejay Diagnostics, Inc. (-6409922.00), less than NRx Pharmaceuticals, Inc. (20.89M),
Company | Enterprise Value | Market cap |
---|---|---|
2.60M | $5.54M | |
-4187996.00 | $3.78M | |
19.23M | $22.70M | |
-6409922.00 | $1.21M | |
20.89M | $14.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biofrontera Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biofrontera Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biofrontera Inc.'s Enterprise Value?
What is the highest Enterprise Value for Biofrontera Inc. (BFRIW)?
What is the 3-year average Enterprise Value for Biofrontera Inc. (BFRIW)?
What is the 5-year average Enterprise Value for Biofrontera Inc. (BFRIW)?
How does the current Enterprise Value for Biofrontera Inc. (BFRIW) compare to its historical average?